A primer to frequent itemset mining for bioinformatics S Naulaerts, P Meysman, W Bittremieux, TN Vu, W Vanden Berghe, ... Briefings in bioinformatics 16 (2), 216-231, 2015 | 156 | 2015 |
Predicting synergism of cancer drug combinations using NCI-ALMANAC data P Sidorov, S Naulaerts, J Ariey-Bonnet, E Pasquier, PJ Ballester Frontiers in chemistry 7, 509, 2019 | 105 | 2019 |
Predicting the Reliability of Drug-target Interaction Predictions with Maximum Coverage of Target Space A Peón, S Naulaerts, PJ Ballester Scientific Reports 7, 3820, 2017 | 60 | 2017 |
Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway K Heyninck, L Sabbe, CS Chirumamilla, KS vel Szic, P Vander Veken, ... Biochemical pharmacology 109, 48-61, 2016 | 59 | 2016 |
Bioinformatics approaches for the functional interpretation of protein lists: from ontology term enrichment to network analysis K Laukens, S Naulaerts, WV Berghe Proteomics 15 (5-6), 981-996, 2015 | 44 | 2015 |
Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells A Palagani, K Op de Beeck, S Naulaerts, J Diddens, ... PLoS One 9 (12), e113842, 2014 | 42 | 2014 |
Mining association rules in graphs based on frequent cohesive itemsets T Hendrickx, B Cule, P Meysman, S Naulaerts, K Laukens, B Goethals Advances in Knowledge Discovery and Data Mining: 19th Pacific-Asia …, 2015 | 35 | 2015 |
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer RS Laureano, J Sprooten, I Vanmeerbeerk, DM Borras, J Govaerts, ... Oncoimmunology 11 (1), 2096363, 2022 | 34 | 2022 |
Osmotic stress inhibits leaf growth of Arabidopsis thaliana by enhancing ARF‐mediated auxin responses S Kalve, BL Sizani, MN Markakis, C Helsmoortel, G Vandeweyer, ... new phytologist 226 (6), 1766-1780, 2020 | 30 | 2020 |
Precision and recall oncology: combining multiple gene mutations for improved identification of drug-sensitive tumours S Naulaerts, CC Dang, PJ Ballester Oncotarget 8 (57), 97025, 2017 | 27 | 2017 |
Varicella-zoster virus-derived major histocompatibility complex class I-restricted peptide affinity is a determining factor in the HLA risk profile for the development of … P Meysman, B Ogunjimi, S Naulaerts, P Beutels, V Van Tendeloo, ... Journal of virology 89 (2), 962-969, 2015 | 24 | 2015 |
Predicting cancer drug response in vivo by learning an optimal feature selection of tumour molecular profiles LC Nguyen, S Naulaerts, A Bruna, G Ghislat, PJ Ballester Biomedicines 9 (10), 1319, 2021 | 12 | 2021 |
Concise polygenic models for cancer-specific identification of drug-sensitive tumors from their multi-omics profiles S Naulaerts, MP Menden, PJ Ballester Biomolecules 10 (6), 963, 2020 | 12 | 2020 |
Machine learning models to predict in vivo drug response via optimal dimensionality reduction of tumour molecular profiles L Nguyen, S Naulaerts, A Bomane, A Bruna, G Ghislat, PJ Ballester bioRxiv, 277772, 2018 | 8 | 2018 |
Multiomics and spatial mapping characterizes human CD8+ T cell states in cancer S Naulaerts, A Datsi, DM Borras, A Antoranz Martinez, J Messiaen, ... Science Translational Medicine 15 (691), eadd1016, 2023 | 7 | 2023 |
Op de Beeck K, Laukens K, Van Camp G, Weseler AR, Bast A, Haenen GR, Haegeman G, Vanden Berghe W (2016) Withaferin A induces heme oxygenase (HO-1) expression in endothelial … K Heyninck, L Sabbe, CS Chirumamilla, K Szarc Vel Szic, ... Biochem Pharmacol 109, 48-61, 0 | 7 | |
Immunogenomic, single-cell and spatial dissection of CD8+T cell exhaustion reveals critical determinants of cancer immunotherapy S Naulaerts, DM Borras, AA Martinez, J Messiaen, Y Van Herck, L Gelens, ... BioRxiv, 2021.11. 22.468617, 2021 | 6 | 2021 |
The interface of tumour-associated macrophages with dying cancer cells in immuno-oncology I Vanmeerbeek, J Govaerts, RS Laureano, J Sprooten, S Naulaerts, ... Cells 11 (23), 3890, 2022 | 5 | 2022 |
T cell–mediated targeted delivery of anti–PD-L1 nanobody overcomes poor antibody penetration and improves PD-L1 blocking at the tumor site PF Petit, R Bombart, PH Desimpel, S Naulaerts, L Thouvenel, JF Collet, ... Cancer Immunology Research 10 (6), 713-727, 2022 | 5 | 2022 |
Tumour immune rejection triggered by activation of α2-adrenergic receptors J Zhu, S Naulaerts, L Boudhan, M Martin, L Gatto, BJ Van den Eynde Nature, 1-9, 2023 | 3 | 2023 |